Chronic Uveitis Following Neodymium-Doped Yttrium Aluminum Garnet Laser Peripheral Iridotomy : Journal of Glaucoma

Secondary Logo

Journal Logo

Advanced Search
Case Report/Small Case Series

Chronic Uveitis Following Neodymium-Doped Yttrium Aluminum Garnet Laser Peripheral Iridotomy

Ali, Amro MD, MOphth*; Rosenfeld, Cyril MD*; Rosenberg, Eric DO*; Sharma, Sansar PhD†; Wandel, Thaddeus L. MD*

Author Information

Departments of *Ophthalmology

†Ophthalmology and Neuroscience, New York Medical College, Valhalla, NY

Disclosure: The authors declare no conflict of interest.

Reprints: Amro Ali, MD, Mophth, Westchester Medical Center-New York Medical College, Valhalla, NY 10595 (e-mail: [email protected]).

Journal of Glaucoma 26(10):p e229-e231, October 2017. | DOI: 10.1097/IJG.0000000000000736

Abstract

Purpose: 

Assessment of a chronic uveitis entity in nonuveitic patients following neodymium-doped yttrium aluminum garnet (Nd:YAG) laser peripheral iridotomy.

Methods: 

A 7-year retrospective observational case series of 5 patients that developed chronic uveitis following a Nd:YAG laser peripheral iridotomy treatment.

Results: 

Five eyes of 5 nonconsecutive patients had developed chronic anterior uveitis lasting >12 weeks. Four patients were female, with a mean age of 60.3 years (range, 48 to 83 y), and a mean follow-up duration of 8 months after initiation of treatment.

Conclusions: 

Chronic anterior uveitis should be addressed as a possible risk in patients undergoing Nd:YAG laser iridotomies. A larger prospective study would be necessary in establishing and exploring the association between these 2 entities.

Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.

Full Text Access for Subscribers:

Not a Subscriber?

Buy
Request Permissions
Become a Society Member

You can read the full text of this article if you:

Access through Ovid